These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27307451)

  • 1. Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity.
    Giuntini S; Granoff DM; Beernink PT; Ihle O; Bratlie D; Michaelsen TE
    Clin Vaccine Immunol; 2016 Aug; 23(8):698-706. PubMed ID: 27307451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein.
    Giuntini S; Reason DC; Granoff DM
    Infect Immun; 2012 Jan; 80(1):187-94. PubMed ID: 22064712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and functional activities of chimeric mouse-human immunoglobulin G and immunoglobulin M antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 epitopes.
    Michaelsen TE; Ihle Ø; Beckstrøm KJ; Herstad TK; Kolberg J; Høiby EA; Aase A
    Infect Immun; 2003 Oct; 71(10):5714-23. PubMed ID: 14500492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity.
    Giuntini S; Beernink PT; Reason DC; Granoff DM
    PLoS One; 2012; 7(3):e34272. PubMed ID: 22461909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis.
    Michaelsen TE; Kolberg J; Aase A; Herstad TK; Høiby EA
    Scand J Immunol; 2004 Jan; 59(1):34-9. PubMed ID: 14723619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, sequencing and expression of immunoglobulin variable regions of murine monoclonal antibodies specific for the P1.7 and P1.16 PorA protein loops of Neisseria meningitidis.
    Ihle Ø; Beckstrøm KJ; Michaelsen TE
    Scand J Immunol; 2003 May; 57(5):453-62. PubMed ID: 12753502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine.
    Aase A; Høiby EA; Michaelsen TE
    Scand J Immunol; 1998 Apr; 47(4):388-96. PubMed ID: 9600322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen.
    Welsch JA; Ram S; Koeberling O; Granoff DM
    J Infect Dis; 2008 Apr; 197(7):1053-61. PubMed ID: 18419542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding.
    Giuntini S; Reason DC; Granoff DM
    Infect Immun; 2011 Sep; 79(9):3751-9. PubMed ID: 21708990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity.
    Giuntini S; Pajon R; Ram S; Granoff DM
    Infect Immun; 2015 Apr; 83(4):1536-45. PubMed ID: 25644002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen.
    Vu DM; Wong TT; Granoff DM
    Vaccine; 2011 Feb; 29(10):1968-73. PubMed ID: 21241734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines.
    Vestrheim AC; Moen A; Egge-Jacobsen W; Bratlie DB; Michaelsen TE
    Scand J Immunol; 2013 May; 77(5):419-28. PubMed ID: 23488770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice.
    Peeters CC; Claassen IJ; Schuller M; Kersten GF; van der Voort EM; Poolman JT
    Vaccine; 1999 Jun; 17(20-21):2702-12. PubMed ID: 10418921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide.
    van den Elsen JM; Herron JN; Hoogerhout P; Poolman JT; Boel E; Logtenberg T; Wilting J; Crommelin DJ; Kroon J; Gros P
    Proteins; 1997 Sep; 29(1):113-25. PubMed ID: 9294871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of IgG subclass antibody responses after immunization with a group B meningococcal outer membrane vesicle vaccine, using monoclonal mouse-human chimeric antibodies as standards.
    Naess LM; Rosenqvist E; Høiby EA; Michaelsen TE
    J Immunol Methods; 1996 Sep; 196(1):41-9. PubMed ID: 8841442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural difference in the complement activation site of human IgG1 and IgG3.
    Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
    Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
    Parzych EM; Gulati S; Zheng B; Bah MA; Elliott STC; Chu JD; Nowak N; Reed GW; Beurskens FJ; Schuurman J; Rice PA; Weiner DB; Ram S
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.
    Granoff DM; Costa I; Konar M; Giuntini S; Van Rompay KK; Beernink PT
    J Infect Dis; 2015 Sep; 212(5):784-92. PubMed ID: 25676468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines.
    Rouppe van der Voort EM; Kuipers B; Brugghe HF; van Unen LM; Timmermans HA; Hoogerhout P; Poolman JT
    FEMS Immunol Med Microbiol; 1997 Mar; 17(3):139-48. PubMed ID: 9093834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease.
    Idänpään-Heikkilä I; Høiby EA; Chattopadhyay P; Airaksinen U; Michaelsen TM; Wedege E
    J Med Microbiol; 1995 Nov; 43(5):335-43. PubMed ID: 7562997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.